Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Zanolimumab [USAN:INN]
RN: 652153-01-0
UNII: HG3L8885M0


  • A human monoclonal antibody targeted against CD4 for the potential treatment of cutaneous and noncutaneous T-cell lymphomas.

Molecular Formula

  • Unspecified

Classification Codes

  • Antineoplastic Agents
  • Antineoplastic Agents, Immunological
  • Treatment of Rheumatoid Arthritis, Psoriasis, Cutaneous and Peripheral T-Cell Lymphoma
* denotes mobile formatted website

Links to Resources

Names and Synonyms

Name of Substance

  • Zanolimumab
  • Zanolimumab [USAN:INN]


  • HuMax CD 4
  • HuMax-CD4
  • MDX 016
  • MDX-016
  • UNII-HG3L8885M0
  • Zanolimumab

Systematic Names

  • Immunoglobulin G1, anti-(human antigen CD4), heavy chain disulfide with the kappa-chain of human monoclonal antibody 6G5.2, dimer
  • Immunoglobulin, anti-(human CD4 (antigen)) (human monoclonal 6G5 heavy chain), disulfide with human monoclonal 6G5 light chain, dimer

Registry Numbers

CAS Registry Number

  • 652153-01-0


  • HG3L8885M0

Other Registry Number

  • 727724-25-6

System Generated Number

  • 0652153010